Annual Cash & Cash Equivalents
N/A
December 1, 2024
Summary
- CI annual cash & cash equivalents is not available.
Performance
CI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
N/A
December 1, 2024
Summary
- CI quarterly cash and cash equivalents is not available.
Performance
CI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CI Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
CI Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Cigna Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.89 B(-13.3%) |
Jun 2024 | - | $6.79 B(-19.6%) |
Mar 2024 | - | $8.44 B(+7.9%) |
Dec 2023 | $7.82 B(+32.0%) | $7.82 B(-7.9%) |
Sep 2023 | - | $8.50 B(-11.4%) |
Jun 2023 | - | $9.59 B(+20.8%) |
Mar 2023 | - | $7.93 B(+33.9%) |
Dec 2022 | $5.92 B(+16.6%) | $5.92 B(-16.3%) |
Sep 2022 | - | $7.08 B(+60.1%) |
Jun 2022 | - | $4.42 B(-0.1%) |
Mar 2022 | - | $4.42 B(-12.9%) |
Dec 2021 | $5.08 B(-50.1%) | $5.08 B(+45.9%) |
Sep 2021 | - | $3.48 B(-8.8%) |
Jun 2021 | - | $3.82 B(-41.3%) |
Mar 2021 | - | $6.50 B(-36.1%) |
Dec 2020 | $10.18 B(+120.4%) | $10.18 B(+90.5%) |
Sep 2020 | - | $5.34 B(-25.6%) |
Jun 2020 | - | $7.18 B(+61.4%) |
Mar 2020 | - | $4.45 B(-3.6%) |
Dec 2019 | $4.62 B(+19.8%) | $4.62 B(+0.9%) |
Sep 2019 | - | $4.58 B(+26.8%) |
Jun 2019 | - | $3.61 B(-27.5%) |
Mar 2019 | - | $4.98 B(+29.1%) |
Dec 2018 | $3.85 B(+29.7%) | $3.85 B(-84.0%) |
Sep 2018 | - | $24.03 B(+561.3%) |
Jun 2018 | - | $3.63 B(+31.1%) |
Mar 2018 | - | $2.77 B(-6.8%) |
Dec 2017 | $2.97 B(-6.7%) | $2.97 B(-18.7%) |
Sep 2017 | - | $3.66 B(+1.2%) |
Jun 2017 | - | $3.61 B(-13.1%) |
Mar 2017 | - | $4.16 B(+30.5%) |
Dec 2016 | $3.19 B(+61.8%) | $3.19 B(-1.2%) |
Sep 2016 | - | $3.22 B(+31.4%) |
Jun 2016 | - | $2.45 B(+2.2%) |
Mar 2016 | - | $2.40 B(+22.0%) |
Dec 2015 | $1.97 B(+38.6%) | $1.97 B(-17.3%) |
Sep 2015 | - | $2.38 B(+20.9%) |
Jun 2015 | - | $1.97 B(-24.8%) |
Mar 2015 | - | $2.62 B(+84.5%) |
Dec 2014 | $1.42 B(-49.2%) | $1.42 B(-12.4%) |
Sep 2014 | - | $1.62 B(-17.6%) |
Jun 2014 | - | $1.97 B(-13.6%) |
Mar 2014 | - | $2.28 B(-18.6%) |
Dec 2013 | $2.79 B(-6.1%) | $2.79 B(-8.5%) |
Sep 2013 | - | $3.06 B(-4.8%) |
Jun 2013 | - | $3.21 B(-2.9%) |
Mar 2013 | - | $3.31 B(+11.0%) |
Dec 2012 | $2.98 B | $2.98 B(+33.2%) |
Sep 2012 | - | $2.24 B(-26.6%) |
Jun 2012 | - | $3.04 B(+44.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $2.11 B(-55.0%) |
Dec 2011 | $4.69 B(+192.2%) | $4.69 B(+146.6%) |
Sep 2011 | - | $1.90 B(+7.2%) |
Jun 2011 | - | $1.77 B(+7.1%) |
Mar 2011 | - | $1.66 B(+3.2%) |
Dec 2010 | $1.60 B(+73.7%) | $1.60 B(+10.8%) |
Jun 2010 | - | $1.45 B(+11.5%) |
Mar 2010 | - | $1.30 B(+40.6%) |
Dec 2009 | $924.00 M(-31.1%) | $924.00 M(+10.5%) |
Sep 2009 | - | $836.00 M(-18.2%) |
Jun 2009 | - | $1.02 B(-25.7%) |
Mar 2009 | - | $1.38 B(+2.5%) |
Dec 2008 | $1.34 B(-31.9%) | $1.34 B(+24.5%) |
Sep 2008 | - | $1.08 B(+33.9%) |
Jun 2008 | - | $805.00 M(-71.8%) |
Mar 2008 | - | $2.85 B(+44.7%) |
Dec 2007 | $1.97 B(+41.5%) | $1.97 B(+38.6%) |
Sep 2007 | - | $1.42 B(+28.7%) |
Jun 2007 | - | $1.10 B(-30.5%) |
Mar 2007 | - | $1.59 B(+14.2%) |
Dec 2006 | $1.39 B(-18.5%) | $1.39 B(+15.2%) |
Sep 2006 | - | $1.21 B(-13.0%) |
Jun 2006 | - | $1.39 B(-27.1%) |
Mar 2006 | - | $1.90 B(+11.4%) |
Dec 2005 | $1.71 B(-32.2%) | $1.71 B(+36.6%) |
Sep 2005 | - | $1.25 B(-33.4%) |
Jun 2005 | - | $1.88 B(-21.7%) |
Mar 2005 | - | $2.40 B(-4.7%) |
Dec 2004 | $2.52 B(+81.0%) | $2.52 B(-13.9%) |
Sep 2004 | - | $2.92 B(-3.6%) |
Jun 2004 | - | $3.03 B(+103.4%) |
Mar 2004 | - | $1.49 B(+7.1%) |
Dec 2003 | $1.39 B(-37.6%) | $1.39 B(-29.0%) |
Sep 2003 | - | $1.96 B(+10.5%) |
Jun 2003 | - | $1.77 B(-13.9%) |
Mar 2003 | - | $2.06 B(-16.8%) |
Sep 2002 | - | $2.48 B(+92.3%) |
Jun 2002 | - | $1.29 B(-20.7%) |
Mar 2002 | - | $1.63 B(+2.5%) |
Sep 2001 | - | $1.58 B(-5.3%) |
Jun 2001 | - | $1.67 B(-18.4%) |
Mar 2001 | - | $2.05 B(+1.7%) |
Sep 2000 | - | $2.02 B(-9.1%) |
Jun 2000 | - | $2.22 B(-11.6%) |
Mar 2000 | - | $2.51 B(+12.5%) |
Dec 1999 | $2.23 B(+12.4%) | $2.23 B(+12.4%) |
Dec 1998 | $1.99 B(+54.3%) | $1.99 B(+54.3%) |
Dec 1996 | $1.29 B(-17.4%) | $1.29 B(-17.4%) |
Dec 1995 | $1.56 B(-7.9%) | $1.56 B(-7.9%) |
Dec 1994 | $1.69 B | $1.69 B |
FAQ
- What is the all time high annual cash & cash equivalents for Cigna?
- What is the all time high quarterly cash and cash equivalents for Cigna?
What is the all time high annual cash & cash equivalents for Cigna?
Cigna all-time high annual cash & cash equivalents is $10.18 B
What is the all time high quarterly cash and cash equivalents for Cigna?
Cigna all-time high quarterly cash and cash equivalents is $24.03 B